Tremfya®
Tremfya® is an interleukin-23 antagonist indicated for the treatment of moderately to severely active ulcerative colitis.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Johnson & Johnson (JNJ) |
CLASS: Monoclonal Antibody |
PRESCRIBED BY: Gastroenterologists
|
HOW ADMINISTERED: Injection or IV infusion, depending on the diagnosis |
FREQUENCY: Ulcerative Colitis: Week 0, Week 4, and Week 8 |
Length of infusion: |
FOR MORE INFORMATION: |
